S0941: A phase 2 SWOG study of sorafenib and erlotinib in patients with advanced gallbladder carcinoma or cholangiocarcinoma

A. B. El-Khoueiry, C. Rankin, A. B. Siegel, S. Iqbal, I. Y. Gong, K. C. Micetich, O. R. Kayaleh, H. J. Lenz, C. D. Blanke

Research output: Contribution to journalArticlepeer-review

67 Scopus citations

Fingerprint Dive into the research topics of 'S0941: A phase 2 SWOG study of sorafenib and erlotinib in patients with advanced gallbladder carcinoma or cholangiocarcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences